PA

Palash Agrawal

Active Director Director DIN 07802836
DIN 07802836 First appointment May 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Palash Agrawal

Data last updated:

Palash Agrawal is a Director at Pms Pharma Private Limited (since 2017). The company operates in Business Services. Pms Pharma Private Limited reported revenue of ₹1.3 Lakh (FY 2022).

DIN 07802836
Primary Designation Director
Industry Business Services
First Appointment 11 May 2017
Oldest Company Age 9 yrs
Largest company Pms Pharma Private Limited · ₹1.3 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pms Pharma Private Limited U74999UP2017PTC093011
Director11 May 20172017₹1.3 Lakh (FY 2022)Active

Board colleagues of Palash Agrawal

NameDINCompanyDesignation
Pankaj Agrawal07802848Pms Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pms Pharma Private Limited
Premium access

Shareholding and investment profile for Palash Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palash Agrawal

Palash Agrawal currently holds 1 directorship: Pms Pharma Private Limited (Director, since 11 May 2017, revenue ₹1.3 Lakh (FY 2022)).

Palash Agrawal was first appointed on 11 May 2017 as Director at Pms Pharma Private Limited.

The current boards of Palash Agrawal's companies include Pankaj Agrawal (Pms Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available